X-Zell Inc.
  1. Companies
  2. X-Zell Inc.
  3. Articles
  4. Case Study A - Next-Gen Cytology

Case Study A - Next-Gen Cytology

SHARE
Jan. 11, 2023
Courtesy ofX-Zell Inc.

X-ZELL is collaborating with one of Germany’s leading cytopathology centres to introduce Cryoimmunostaining™ into routine cytology as a tool to efficiently analyse lung fluids such as bronchoalveolar lavage and pleural effusion and enable near-instant diagnoses through digital on-screen analysis.

According to the German Association of Pathology (BdP), X-ZELL Cryoimmunostaining™ is eligible for reimbursement under the EBM and GOÄ systems.

  • 93 per cent time reduction from sample to diagnosis by eliminating cell block preparation
  • 700% per cent data increase per sample through multi-channel immunostaining
  • More capacity on existing IHC equipment due to reduced restaining
Most popular related searches

Contact supplier

Drop file here or browse